Professional Documents
Culture Documents
Microwave Assisted Synthesis of Novel Benzotriazole - Pyrazoline derivatives and its Pharmacological Evaluation
Kalmendra Singh Sisodiya1*, Manisha2, Amit Sahu3, V.K.Sharma4 and Bharat Parashar5
Department of Chemistry, Pacific University, Udaipur, India. Skyline Institute of Engineering and Technology, Greater Noida (U.P.), India 3 Department of Chemistry, Techno India NJR instituted of technology Udaipur, India 4 Department of Chemistry, M.L. Sukhadia University, Udaipur, (Rajasthan) 5 Department of pharmaceutics, M.B.University; Solan (H.P.).
2 1
Abstract: A solvent free approach for organic synthesis is described here which involve microwave exposure of neat reactants. A novel and simple method have been developed for the synthesis of some Benzotriazole - Pyrazoline derivatives under microwave irradiation. In addition, these compounds were obtained with conventional heating procedures and microwave irradiation to compare them with those obtained with solid support synthesis. All the compounds synthesized were characterized by running TLC, Elemental analysis, IR, NMR and MS spectra. Consequently, the solid support synthesis method provided nearly the same and higher product yields in a very short period of time. These results suggest that in addition, the use of solid supports in conjunction with microwave leads to a higher yield, remarkable reactions rate enhancement and high catalytic activity with the optimum utilization of energy. Solid support synthesis method is more useful than the microwave irradiation method and conventional method. Keywords: Green chemistry, microwave irradiation, solid supported synthesis,
benzotriazole - pyrazoline derivatives, neat reaction technology
Microwave...
INTRODUCTION
Classical methods require elaborate apparatus setup, longer heating time and large volume of organic solvents and there is virtually no control over the energy input. Hazardous chemicals and by products of various reactions increasing pollution in the environment. Keeping in view the need for avoiding hazardous chemicals and solvents in chemical reactions, microwave technique was found to be accelerating a wide variety of transformations. Neat reaction technology is a step forward in the direction of solvent free reactions and an alternative approach that eliminates the use of a solid support as well as solvent from the reaction. In recent years design of environmentally benign reactions is an important goal in organic synthesis. Microwave induced Organic Reaction Enhancement (MORE) chemistry offers a simple, non-conventional technique for the synthesis of a wide variety of compounds having medicinal, pharmaceutical and commercial importance. In this expeditious and solvent free approach the reactants were adsorbed over inorganic supports and exposed to microwave irradiation. In recent years the use of microwaves1,2 has been well established as a pollution free technique which allows reaction to occur on a preparative scale in open vessels under solvent free conditions which avoids the risk of high pressures and explosions. Microwave activation rather than conventional heating is preferred, as solid supports are rather poor thermal conductors but strong microwave absorbents, which results in lesser evaporation of solvents preventing pollution3. Further the reactions are generally faster and the products obtained are of high purity4, 5. Pyrazole as well as pyrazolines containing compounds have been reported to show a broad spectrum of biological activities such as antimicrobial6-9, anti-tumor10, and antiinflammatory11, 12 agents. Due to bioactivity associated with pyrazole and pyrazolines containing compounds, researchers and chemist are very much interested in pyrazole chemistry13-15. Pyrazolone are associated with broad spectrum of biological activities16, Pyrazolone exhibit anti-inflammatory17 and analagics activity 18, anticancer activity19, 20 antiamoebic activity21 , antitubercular activity22 and antitumor activity23 . Synthesis of some Benzotriazole - Pyrazoline derivatives under microwave irradiation using diethyl malonate, acetyl acetone, 1- Chloro-hexane 2-4 dione, ethyl 2-cyanoacetate and phenyl isothiocynate by solid support synthesis method, conventional heating procedures and microwave irradiation method were done. The reaction carrierd out in absolute alcohol or DMF using conventional method required 4-10 h, while microwave irradiation method require only 3.30-7 min and solid support method using silica gel require only 4-6.50 min. The synthetic route of above mentioned compound is shown in Scheme 1, (Table 1). MATERIALS AND METHODS Experimental Section: All the irradiation was carried out in a modified microwave oven (Kenstar, model no: OM26.EGO). Melting points of synthesis compounds were determined in open capillaries in liquid paraffin and are uncorrected. Purity of the compounds in addition to elemental analysis were verified by percolated TLC using silica gel G as a adsorbent using ethyl acetate: n-hexane (7:3) as a eluent and spot was detected by using iodine vapours. The IR (KBr pellets) spectra were recorded on a Perkin Elimer1800- spectrophotometer and H1NMR spectra were recorded on BRUKER DRX-300MHz spectrophotometer, (TMS as a internal reference) and chemical shifts are expressed in . Mass spectra were recorded on Jeol D30 spectrophotometer. Elemental analyses for C, H and N were conducted using a Perkin -Elmer C, H, and N analyzer. Their result was found to be an in good agreement with the calculated values (0.4%).
Microwave ...
NH O
O O Cl
K2CO3
N N
OO
(I)
NH2NH2.H2O
N N
(II)
HN N
Scheme No. 1
O N HN N O O
N N
O N N N O
N N
1-(2-(1Hbenzo[d][1,2,3]triazol-1O yl)acetyl)pyrazolidine-3,5dione
(1)
N S N NH N O O N N
1-(2-(1H-benzo[d][1,2,3]triazol-1yl)acetyl)-2-acetylpyrazolidine-3,5dione
(2)
CH2 (COOC2H5 )2
(E)-N-(4-oxo-2-(phenylimino)thiazolidin-3yl)-1H-benzo[d][1,2,3]triazole-1carboxamide
(8) (i)Morpholine
H3C N N N N N O CH3
CH 3 CO
2-(1H-benzo[d][1,2,3]triazol-1yl)-1-(3,5-dimethyl-4,5dihydropyrazol-1-yl)ethanone
(3)
CH 2 CO C
O O N N Cl N N N
H3 CH 2C H CO COC 2 ClCH 2
)2 H5 C2 OO (C 2 CH
OH CO CH 3
N
H
3
(ii)ClCH2COOC2H 5
N H2N N
(II)
C6H5NCS
N H N HN N H S
NH O
CH
(7)
CH3COCH2COCH2CH3
O N N N N N
1-(2-(1H-benzo[d][1,2,3]triazol1-yl)acetyl)-3-(chloromethyl)1H-pyrazol-5(4H)-one
(4)
H3C N H2N N N O N N O
1-(2-(1H-benzo[d][1,2,3]triazol-1-yl)acetyl)3-amino-1H-pyrazol-5(4H)-one
(6)
1-(2-(1H-benzo[d][1,2,3]triazol-1yl)acetyl)-3-methyl-1H-pyrazol-5(4H)one
(5)
Scheme-2
The synthetic route of compounds (1-8) 110 IJGHC; 2012, Vol.1, No.2, 108-120.
Microwave...
Table: 1- Comparative Analysis of Conventional and Microwave Methods Comp Molecular formula M.wt Condition Conventional method Microwave method m. p o C On Solid Support Yield R time (%) (min) 88 6.10 86 90 88 90 92 90 86 6.30 3.30 5.30 5.20 2.20 2.10 3.10 Rf
In solvent Yield (%) 70 68 71 72 71 73 69 R time(h) 6.00 5.10 8.10 5.22 6.12 4.55 4.11 5.50 Yield (%) 82 80 84 81 83 84 82 80 R time (min) 3.00 5.10 3.10 3.30 3.00 3.00 2.00 2.30
1 2 3 4 5 6 7 8
17 2 18 9 16 9 20 1 16 9 18 2 21 0 23 2
Microwave ...
2H, CH2 ) , 3.35 (s, 2H, CH2), MS (m/z+) [M+] 259; Anal.Calc.for C11H9N5O3; C, 50.97; H, 3.50; N, 27.02; Found: C, 51.26.; H, 3.30; N, 26.82.
Microwave...
Physical and Spectral Analysis of Compound 3: Mol. Wt. 257; M.P. 169-171 C; Yield: 90 %; Rf :0.68; IR ( KBr cm-1): 3110 (Aromatic CH-Ar, str. ), 2265 (N=N), 1690, (C=O), 1553(C=N), : 1H NMR (400 MHz, DMSO-d6) : 7.32- 7.82 (4H, m, Ar-H); 5.71(s, 1H, CH) , 4.56 (s, 2H, CH2 ) , 3.42 (s, 2H, CH2), 3.35 (s, 3H, CH3), 2.40 (s, 3H, CH3 ): MS (m/z+) [M+] 257 ; Anal. Calc.for C13H13N5O; C, 60.69; H, 5.88; N, 27.22; Found: C, 60.92; H, 5.62; N, 27.50.
Microwave ...
filtered and washed several times with water. Purification by recrystallization with alcohol gave product 5. Physical characteristic of compound is recorded in Table No 1. Physical and Spectral Analysis of Compound 5: Mol. Wt. 257; M.P. 169-171 C; Yield: 90 %; Rf :0.68; IR ( KBr cm-1): 3115 (Aromatic CH-Ar str. ), 2262 (N=N), 1680, 1606 (C=O), 1530 (C=N), ; 1H NMR (400 MHz, DMSO-d6) : 7.40- 7.88 (4H, m, Ar-H); 4.56 (s, 2H, CH2 ) , 3.42 (s, 2H, CH2), 3.35 (s, 3H, CH3), : MS (m/z+) [M+] 257 ; Anal. Calc.for C12H11N5O2; C, 56.03; H, 4.31; N, 27.22; Found: C, 56.36; H, 4.64; N, 27.46.
Microwave...
recrystallize from alcohol to give product 7. Physical characteristic of compound is recorded in Table No 1. Physical and Spectral Analysis of Compound 7: Mol. Wt. 326; M.P. 210-2111 C; Yield: 90 %; Rf :0.66; IR ( KBr cm-1): 3416,3372, 3312(-NH), 3089 (Aromatic CH-Ar str. ), 2262 (N=N), 1708 (C=O), 1100 (C=S), ; 1H NMR (400 MHz, DMSO-d6) : 10.20 (s,H, HN-CO), 7.48- 7.80 (m, 9H, Ar-H); 4.34 (s,H,HN-Ph), 3.42 (s, 2H, CH2), 2.20 (s,H,HN-N); : MS (m/z+) [M+] 326 ; Anal. Calc.for; C15H14N6OS ; C, 55.20; H, 4.32; N, 25.75; Found: C, 55.20; H, 4.32; N, 25.75.
BIOLOGICAL ASSAY
All the newly synthesized compounds were tested in vitro for antimicrobial activity against four bacterial strains two-gram positive bacteria (Bacillus subtilis and staphylococcus aureus) and two-gram negative bacteria (Escherichia coli and P.aeruginosa) and antifungal activity against Candida albicans and Asperigillus niger at the concentration of 200,100,50, g/ml by using the cup plate agar disk diffusion method24,25 and determination of minimum inhibitory concentration (MIC) by broth dilution method.The concentration used in screening was choosen after determining MIC of each compound. The dimethylsulfoxide (DMSO) was used as a solvent. For this method, Mueller-Hinton agar was used as the growth medium for the bacterial strains and Sabouraud agar was growth medium for fungal species. The sterilized agar media were poured in to petridishes and allow solidifying. On the surface of the media microbial suspension were spread with the help of sterilized triangular loop. (Inoculums of standard suspension 0.1 mL of the test organism strain which contains 106 bacilli/mL) A stainless steel cylinder of 9 mm diameter (pre sterilized) was used to bore the cavities. In to these well were added 0.1mL portion of the test compounds in solvent DMSO. The drug solution was allowed to diffuse for about an hour in to the medium. The petridishes used for antibacterial screening were 115 IJGHC; 2012, Vol.1, No.2, 108-119.
Microwave ...
incubated at 37 1C for 24 h, while those for antifungal activity were incubated at 28 1C for 48-72 h. DMSO was used as a control for all the type of microorganisms. The control showed no activity against the strains of microorganisms used. Antimicrobial activity and antifungal activity was measured as a function of diameter of zone of inhibition (mm). The result was compared with standard drugs Ciprofloxacin for antibacterial activity and fluconazole for antifungal activity by measuring the zone of inhibition in mm at 200,100 and 50 g/mL (Table -2 and Table-3). The lowest concentration, which showed no visible growth, was taken as an end point minimum inhibitory concentration (MIC). For antibacterial activity, in present protocol 50 g/ml is considered as active as compared to the standard drug Ciprofloxacin. For antifungal activity, 50 g/mL is considered as active as compared to standard fluconazole
1 2 3 4 5 6 7 8 Fluconazole
(-)< 6mm; (+) = 7 - 10 mm; (++) =11 15 mm; (+++) = 16 - 21mm; (++++) = 22 - 28mm.
Microwave...
Kalmendra Singh et al. Table: 3. Antibacterial Activities of the synthesized compounds (1-8).
Antibacterial activity Comp E. coli ounds 50 100 g g /ml /ml 1 _ ++ 2 _ ++ 3 + ++ 4 + +++ 5 _ + 6 _ ++ 7 _ + 8 _ +++ Ciprofl ++++ ++++ oxacin
P. aeruginosa 200 g /ml ++ +++ ++++ ++++ +++ +++ +++ ++++ ++++ 50 g /ml _ _ _ _ _ _ _ + ++++ 100 g /ml + _ ++ + + + + ++ ++++ 200 g /ml ++ + ++ ++ +++ + +++ +++ ++++
B. subtitis 50 g /ml _ _ _ _ _ _ _ + ++++ 100 g /ml ++ ++ ++ ++ ++ ++ ++ ++ ++++ 200 g /ml ++ +++ +++ ++++ ++ +++ +++ +++ ++++
S. aureus 50 g /ml _ _ _ _ _ _ _ _ ++++ 100 g /ml _ ++ ++ ++ ++ _ + + ++++ 200 g /ml + +++ ++ +++ +++ +++ +++ +++ ++++
(-)< 6mm; (+) = 7 - 10 mm; (++) =11 15 mm; (+++) = 16 - 21mm; (++++) = 22 - 28mm.
The compound (3) 2-(1H-benzo[d][1,2,3]triazol-1-yl)-1-(3,5-dimethyl-4,5-dihydropyrazol-1-yl)ethanone was synthesized by irradiating mixture of compound (II) and acetyl acetone. The IR spectrum exhibited bands due to 1553(C=N) ,1H NMR (400 MHz, DMSO-d6) showed peaks due to 3.35(s, 3H, CH3), 2.40 (s, 3H, CH3 ) ) and molecular ion peak [M+] was found at 257 which confirmed the formation of compound (3). The compound (4) 1-(2-(1H-benzo[d][1,2,3]triazol-1-yl)acetyl)-3-(chloromethyl)-1H-pyrazol-5(4H)-one was synthesized by microwave irradiation of mixture of compound (II) and 1- Chloro-hexane 2-4 dione. The IR spectrum exhibited bands due to 1695, 1666 (C=O), 1606(C=N), 1H NMR (400 MHz, DMSO-d6) showed peaks due to 4.30 (s, 2H, CH2 ) , 3.22 (s, 2H, CH2) and molecular ion peak [M+] was found at 291; which confirmed formation of compound (4). The compound (5) 1-(2-(1H-benzo[d][1,2,3]triazol-1-yl)acetyl)-3-methyl-1H-pyrazol-5(4H)-one was synthesized by microwave irradiation of mixture of compound (II), hexane-2, 4-dione and acetic acid. The IR spectrum exhibited bands due to 1680,1606(C=O),1530(C=N) and 1H NMR (400 MHz, DMSOd6) showed peaks due to 3.42 (s, 2H, CH2), 3.35 (s, 3H, CH3) and molecular ion peak [M+] was found at 257 which confirmed formation of compound (5). The compound (6) 1-(2-(1H-benzo[d][1,2,3]triazol-1-yl)acetyl)-3-amino-1H-pyrazol-5(4H)-one was synthesized by microwave irradiation of mixture of compound (II) and ethyl 2-cyanoacetate. The IR spectrum exhibited bands due to 1698, 1672 (C=O), 1554(C=N) and NMR (400 MHz, DMSO-d6) showed peaks due to 5.12 (s, 2H, NH2), 4.50 (s, 2H, CH2 ) , 3.42 (s, 2H, CH2) and molecular ion peak [M+] was found at 258 which confirmed formation of compound (6). The compound (7) 1-(2-(1H-benzo[d][1,2,3]triazol-1-yl)acetyl)-4-phenylthiosemicarbazide was synthesized by microwave irradiation of mixture of compound (II) and phenyl isothiocynate in DMF . The IR spectrum exhibited bands due to 1100(C=S), NMR (400 MHz, DMSO-d6) showed peaks due to (s, 117 IJGHC; 2012, Vol.1, No.2, 108-119.
Microwave ...
2H, CH2), 2.20 (s, H, HN-N), and molecular ion peak [M+] was found at 326 which confirmed formation of compound (7). The compound (8) (E)-N-(4-oxo-2-(phenylimino) thiazolidin-3-yl)-1Hbenzo[d][1,2,3]triazole-1carboxamide was synthesized by irradiating mixture of compound (7) andethylchloroacetate in presence of catalytic amount of morpholine. The IR spectrum exhibited bands due to1698, 1649(C=O), 740(S-C-S), NMR (400 MHz, DMSO-d6) showed peaks due to 4.10 (s, 2H, CH2) and molecular ion peak [M+] was found at 352 which confirmed formation of compound(8).
CONCLUSION
Most of the synthesized compounds were found to possess mild to moderate antibacterial and antifungal activity except a couple of compounds which showed excellent activity, almost equivalent to the compounds will take place which may lead to a potentially improved compounds.
ACKNOWLEDGEMENTS
The authors are thankful to Dr.Suman Jain, Director of shri ram college of Pharmacy, for providing laboratory facilities authors are also thankful to Director, CDRI Lucknow, India for providing spectral and analytical data. Special thanks to Dr. Ashok Kumar Sharma (A.D.) Regional Disease Diagnostic Center, Kota (Rajasthan) for antimicrobial screening.
REFERENCES
1. P.Malhotra, S.Pattan, A.P. Nikalje; I. J. Pharm. and Pharma. Sci.; 2010, 2(2): 21. 2. S.K. Sahu, M.Banerjee, A.Samantray, C.Behera and M.A.Azam; Tropical Journal of Pharmaceutical Research; 2008, 7(2): 961. 3. A.H.Kategaonkar, S.A.Sadaphal, K.S.Shelke, B. Shingate, M.S. Shingare; Ukrainica Bioorga. Acta; 2009, 1: 3. 4. B.Parashar, A.Jain, S.Bharadwaj, V.K.Sharma, Med. Chem. Res.; 2010, 17:123. 5. R.Chawla, U. Sahoo, A. Arora, P.C.Sharma, V.Radhakrishnan; Acta Polo Pharma; 2010, 67:55. 6. U.Tripathi, A.Siddiqui, J.S.Solanki, M.S. Ahmad, A. Bhardwaj and T.R. Thapak Turk J Chem.; 2009, 33: 257. 7. B.C.Revanasiddappa, R.N. Rao, E.V.S. Subrahmanyam and D.Satyanarayana; E. J. of Chem.; 2010, 7(1): 295 8. S.Kumar, S. Bawa, S. Drabu, R. Kumar and H.Gupta; Drug Dis; 2009, 4: 154. 9. S.Venkataraman, S. Jain, K.Shah and N.Upmanyu; Acta.Polo.Pharm.Drug Res.; 2010, 67: 361. 10. K.L.Stirrett, J.A. Ferreras, V. Jayaprakash, B.N. Sinha and T.Renc; Bioorg .Med Chem. Lett.; 2008, 18:2662. 11. M.Amir, H. Kumar and A.S.Khan; Bioorg. Med.Chem. Lett.; 2008, 18(3): 918. 12. G.Rathish, K.Jawed, S. Ahmad, S.Bano, M.S.Alam, K.K.Pillai, S.Singh and V.Bagchi; Bioorg. Med. Chem. Lett.; 2008, 9(1):255. 118 IJGHC; 2012, Vol.1, No.2, 108-120.
14. B.Kumar, V.Pathak, S. Rani, R.Kant and I.C.Tewari; Int. J. of Micro. Res.; 2009, 1(2): 20. 15. B.A.Wahab, H.A. Aziz and E.M.Ahmed; Eur. J. Med. Chem.; 2008, 43:1. 16. V.H.Babu, C.H.Sridevi, A. Joseph, K.K. Srinivasan; .I. J. of Pharma. Sci.; 2007, 69 :( 3) 470. 17. S.K.Sahu, M.Banerjee, A. Samantray, C.Behera and M.A.Azam; Tropical Journal of Pharmaceutical Research; 2008, 7 (2): 961. 18. M.Amir, H. Kumar and A.Suroor. Khan; Bio & Med. Chem. Lett.; 2008, 18 (3): 918. 19. A.Ozdemir and Z.G.Asim; Turk. J. Chem.; 2008, 32:529. 20. M.Shaharyar, M.M.Abdullah, M.A.Bakht and J. Majeedt; Eur. J. Med.Chem.; 2010, 45(1): 114. 21. M.Abid,A.R. Bhat, F.Athar and A. Azam; Eur. J. Med. Chem.;2007, 42:1. 22. B.A.Bhat, K.L.Dhar, S.C. Puri, A.K.Saxena, M. Shanmugave and G.N.Qazi; Bioorg. Med. Chem.Lett.; 2005, 15:3177. 23. K.L.Stirrett,J.A Ferreras,V. Jayaprakash, B.N. Sinha and T.Renc; Bioorg. Med. Chem. Lett.; 2008, 18:2662. 24. C.Perez, M.Paul and P.Bezique; Alta. Biomed.; 1990, 15; 113. 25. N.G.Kelekci, S. Koyunoglu, S.Yabanoglu, K.Yelekci, O. Ozgen, G.Ucar, K. Erol, E.Kendi and A.Yesilada; Bioorg. Med. Chem.; 2008, 22: 23.